Cullinan Therapeutics, Inc. (CGEM)
21.85
+0.17
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
21.85
0.00 (0.00%)
After-Hours: 20:00
Cullinan Therapeutics 1 Year Total Returns (Daily) : 182.7% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 182.7% |
| August 20, 2026 | 186.2% |
| August 19, 2026 | 197.1% |
| August 18, 2026 | 162.1% |
| August 17, 2026 | 168.8% |
| August 14, 2026 | 168.3% |
| August 13, 2026 | 157.1% |
| August 12, 2026 | 169.6% |
| August 11, 2026 | 176.9% |
| August 10, 2026 | 150.6% |
| August 07, 2026 | 152.2% |
| August 06, 2026 | 127.8% |
| August 05, 2026 | 117.9% |
| August 04, 2026 | 121.0% |
| August 03, 2026 | 111.9% |
| July 31, 2026 | 112.4% |
| July 30, 2026 | 114.7% |
| July 29, 2026 | 106.4% |
| July 28, 2026 | 112.3% |
| July 27, 2026 | 113.1% |
| July 24, 2026 | 105.3% |
| July 23, 2026 | 107.4% |
| July 22, 2026 | 117.6% |
| July 21, 2026 | 140.2% |
| July 20, 2026 | 132.4% |
| Date | Value |
|---|---|
| July 17, 2026 | 127.7% |
| July 16, 2026 | 114.0% |
| July 15, 2026 | 139.3% |
| July 14, 2026 | 125.8% |
| July 13, 2026 | 132.1% |
| July 10, 2026 | 131.2% |
| July 09, 2026 | 135.6% |
| July 08, 2026 | 150.7% |
| July 07, 2026 | 144.7% |
| July 06, 2026 | 128.0% |
| July 02, 2026 | 127.2% |
| July 01, 2026 | 126.2% |
| June 30, 2026 | 141.8% |
| June 29, 2026 | 137.4% |
| June 26, 2026 | 137.4% |
| June 25, 2026 | 133.3% |
| June 24, 2026 | 125.1% |
| June 23, 2026 | 134.2% |
| June 22, 2026 | 125.6% |
| June 18, 2026 | 84.19% |
| June 17, 2026 | 73.56% |
| June 16, 2026 | 55.03% |
| June 15, 2026 | 58.07% |
| June 12, 2026 | 53.07% |
| June 11, 2026 | 44.54% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Rallybio Corp. | 254.2% |
| MapLight Therapeutics, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 319.8% |
| Oncolytics Biotech, Inc. | -16.52% |
| Sangamo Therapeutics, Inc. | -75.17% |